首页> 外文期刊>Cancer Informatics >Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System
【24h】

Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System

机译:ER(-)乳腺癌模型系统的推断中心调节子的主要功能转录组。

获取原文
           

摘要

We aimed to find clinically relevant gene activities ruled by the signal transducer and activator of transcription 3 (STAT3) proteins in an ER(-) breast cancer population via network approach. STAT3 is negatively associated with both lymph nodal category and stage. MYC is a component of STAT3 network. MYC and STAT3 may co-regulate gene expressions for Warburg effect, stem cell like phenotype, cell proliferation and angiogenesis. We identified a STAT3 network in silico showing its ability in predicting its target gene expressions primarily for specific tumor subtype, tumor progression, treatment options and prognostic features. The aberrant expressions of MYC and STAT3 are enriched in triple negatives (TN). They promote histological grade, vascularity, metastasis and tumor anti-apoptotic activities. VEGFA, STAT3, FOXM1 and METAP2 are druggable targets. High levels of METAP2, MMP7, IGF2 and IGF2R are unfavorable prognostic factors. STAT3 is an inferred center regulator at early cancer development predominantly in TN.
机译:我们的目的是通过网络方法在ER(-)乳腺癌人群中寻找由信号转导子和转录激活因子3(STAT3)激活的基因相关的临床相关基因活性。 STAT3与淋巴结类别和分期都负相关。 MYC是STAT3网络的组成部分。 MYC和STAT3可以共同调节Warburg效应,干细胞表型,细胞增殖和血管生成的基因表达。我们在计算机上鉴定了一个STAT3网络,该网络显示出其预测其靶基因表达主要针对特定​​肿瘤亚型,肿瘤进展,治疗选择和预后特征的能力。 MYC和STAT3的异常表达富含三阴性(TN)。它们促进组织学分级,血管分布,转移和肿瘤抗凋亡活性。 VEGFA,STAT3,FOXM1和METAP2是可药物治疗的靶标。高水平的METAP2,MMP7,IGF2和IGF2R是不利的预后因素。 STAT3是主要在TN癌症早期发展中推断的中心调控因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号